Breaking News
Get 55% Off 0
🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% each
Unlock Stocks
Close

Bosera Medical&hlth Care Set Secs Invt A (050026)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
2.392 -0.040    -1.73%
05:00:00 - Closed. Currency in CNY
  • Morningstar Rating:
  • Total Assets: 2.56B
Type:  Fund
Market:  China
Issuer:  Bosera Asset Management Co., Limited
Asset Class:  Equity
Bosera Medical&Hlth Care Set Secs Invt A 2.392 -0.040 -1.73%

050026 Holdings

 
Comprehensive information about top holdings and Key Holding Information for the Bosera Medical&Hlth Care Set Secs Invt A (050026) fund. Our Bosera Medical&Hlth Care Set Secs Invt A portfolio information includes stock holdings, annual turnover, top 10 holdings, sector and asset allocation.

Asset Allocation

Create Alert
Add to Watchlist
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Name  Net %  Long %  Short %
Cash 7.150 7.150 0.000
Shares 79.050 79.050 0.000
Convertible 0.240 0.240 0.000
Other 13.560 13.560 0.000

 Style Box

Value & Growth Measures

Ratios Value Category Average
P/E Ratio 20.635 24.124
Price to Book 2.322 3.013
Price to Sales 2.515 3.867
Price to Cash Flow 11.822 15.880
Dividend Yield 2.865 1.889
5 Years Earnings Growth 11.081 13.292

Sector Allocation

Name  Net % Category Average
Healthcare 93.520 95.436
Utilities 2.140 2.140
Consumer Defensive 1.510 3.141
Industrials 1.420 0.432
Financial Services 0.700 4.613
Consumer Cyclical 0.690 1.238
Technology 0.020 0.421

Region Allocation

  • Asia
  • Emerging Markets

Top Holdings

Number of long holdings: 109

Number of short holdings: 1

Name ISIN Weight % Last Change %
  Kelun Pharm A CNE100000PW7 6.90 31.14 +1.76%
  Jiangsu Hengrui CNE0000014W7 5.85 47.70 -1.55%
  Cr Sanjiu A CNE0000011K8 3.74 48.10 -0.72%
  Double Medical Tech CNE1000032W7 3.34 33.06 -1.20%
  Beijing Tongrentang CNE000000R69 3.01 41.01 -2.36%
  Chongqing Taiji Industry CNE000000TQ2 2.56 26.29 -2.67%
  Andon Health A CNE100000Q84 2.44 44.49 -1.13%
  Chongqing Genrix Biopharmaceutical CNE100006KG8 2.29 26.54 -5.99%
  Xianju Pharm A CNE100000K64 2.05 12.64 +0.40%
  Dong-E E-Jiao A CNE0000006Y9 1.97 58.38 -1.47%

Top Equity Funds by Bosera Asset Management Co., Limited

  Name Rating Total Assets YTD% 3Y% 10Y%
  Bosera S&P 500 QDII 14.26B 20.37 11.35 13.11
  BoseraYufu CSI 300 Index Fund A 7.14B 14.03 -4.52 8.55
  BoseraYufu CSI 300 Index Fund C 7.14B 13.64 -4.90 -
  Bosera Theme Industry Stock FdLOF 5.72B 0.69 -12.06 7.64
  Bosera Value Growth Fund 2.01B 11.03 -5.83 3.75
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

050026 Comments

Write your thoughts about Bosera Medical&hlth Care Set Secs Invt A
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email